Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation

Evolutionary implications of the uricase loss in hominids

Christina Cicerchi, Nanxing Li, James Kratzer, Gabriela Garcia, Carlos A. Roncal-Jimenez, Katsuyuki Tanabe, Brandi Hunter, Christopher J. Rivard, Yuri Y. Sautin, Eric A. Gaucher, Richard J. Johnson, Miguel A. Lanaspa

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Reduced AMP kinase (AMPK) activity has been shown to play a key deleterious role in increased hepatic gluconeogenesis in diabetes, but the mechanism whereby this occurs remains unclear. In this article, we document that another AMP-dependent enzyme, AMP deaminase (AMPD) is activated in the liver of diabetic mice, which parallels with a significant reduction in AMPK activity and a significant increase in intracellular glucose accumulation in human HepG2 cells. AMPD activation is induced by a reduction in intracellular phosphate levels, which is characteristic of insulin resistance and diabetic states. Increased gluconeogenesis is mediated by reduced TORC2 phosphorylation at Ser171 by AMPK in these cells, as well as by the up-regulation of the rate-limiting enzymes PEPCK and G6Pc. The mechanism whereby AMPD controls AMPK activation depends on the production of a specific AMP downstream metabolite through AMPD, uric acid. In this regard, humans have higher uric acid levels than most mammals due to a mutation in uricase, the enzyme involved in uric acid degradation in most mammals, that developed during a period of famine in Europe 1.5 × 10 7 yr ago. Here, working with resurrected ancestral uricases obtained from early hominids, we show that their expression on HepG2 cells is enough to blunt gluconeogenesis in parallel with an up-regulation of AMPK activity. These studies identify a key role AMPD and uric acid in mediating hepatic gluconeogenesis in the diabetic state, via a mechanism involving AMPK down-regulation and overexpression of PEPCK and G6Pc. The uricase mutation in the Miocene likely provided a survival advantage to help maintain glucose levels under conditions of near starvation, but today likely has a role in the pathogenesis of diabetes.

Original languageEnglish
Pages (from-to)3339-3350
Number of pages12
JournalFASEB Journal
Volume28
Issue number8
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Urate Oxidase
Adenylate Kinase
AMP Deaminase
Hominidae
Medical problems
Starvation
Uric Acid
Gluconeogenesis
Glucose
Liver
Mammals
Hep G2 Cells
Adenosine Monophosphate
Up-Regulation
Enzymes
Chemical activation
Mutation
Phosphorylation
Metabolites
Insulin Resistance

Keywords

  • Gluconeogenesis
  • Insulin
  • Phosphate
  • Urate

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation : Evolutionary implications of the uricase loss in hominids. / Cicerchi, Christina; Li, Nanxing; Kratzer, James; Garcia, Gabriela; Roncal-Jimenez, Carlos A.; Tanabe, Katsuyuki; Hunter, Brandi; Rivard, Christopher J.; Sautin, Yuri Y.; Gaucher, Eric A.; Johnson, Richard J.; Lanaspa, Miguel A.

In: FASEB Journal, Vol. 28, No. 8, 2014, p. 3339-3350.

Research output: Contribution to journalArticle

Cicerchi, C, Li, N, Kratzer, J, Garcia, G, Roncal-Jimenez, CA, Tanabe, K, Hunter, B, Rivard, CJ, Sautin, YY, Gaucher, EA, Johnson, RJ & Lanaspa, MA 2014, 'Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: Evolutionary implications of the uricase loss in hominids', FASEB Journal, vol. 28, no. 8, pp. 3339-3350. https://doi.org/10.1096/fj.13-243634
Cicerchi, Christina ; Li, Nanxing ; Kratzer, James ; Garcia, Gabriela ; Roncal-Jimenez, Carlos A. ; Tanabe, Katsuyuki ; Hunter, Brandi ; Rivard, Christopher J. ; Sautin, Yuri Y. ; Gaucher, Eric A. ; Johnson, Richard J. ; Lanaspa, Miguel A. / Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation : Evolutionary implications of the uricase loss in hominids. In: FASEB Journal. 2014 ; Vol. 28, No. 8. pp. 3339-3350.
@article{1af75ef00b1449e9aa80c8967cf5f7dc,
title = "Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: Evolutionary implications of the uricase loss in hominids",
abstract = "Reduced AMP kinase (AMPK) activity has been shown to play a key deleterious role in increased hepatic gluconeogenesis in diabetes, but the mechanism whereby this occurs remains unclear. In this article, we document that another AMP-dependent enzyme, AMP deaminase (AMPD) is activated in the liver of diabetic mice, which parallels with a significant reduction in AMPK activity and a significant increase in intracellular glucose accumulation in human HepG2 cells. AMPD activation is induced by a reduction in intracellular phosphate levels, which is characteristic of insulin resistance and diabetic states. Increased gluconeogenesis is mediated by reduced TORC2 phosphorylation at Ser171 by AMPK in these cells, as well as by the up-regulation of the rate-limiting enzymes PEPCK and G6Pc. The mechanism whereby AMPD controls AMPK activation depends on the production of a specific AMP downstream metabolite through AMPD, uric acid. In this regard, humans have higher uric acid levels than most mammals due to a mutation in uricase, the enzyme involved in uric acid degradation in most mammals, that developed during a period of famine in Europe 1.5 × 10 7 yr ago. Here, working with resurrected ancestral uricases obtained from early hominids, we show that their expression on HepG2 cells is enough to blunt gluconeogenesis in parallel with an up-regulation of AMPK activity. These studies identify a key role AMPD and uric acid in mediating hepatic gluconeogenesis in the diabetic state, via a mechanism involving AMPK down-regulation and overexpression of PEPCK and G6Pc. The uricase mutation in the Miocene likely provided a survival advantage to help maintain glucose levels under conditions of near starvation, but today likely has a role in the pathogenesis of diabetes.",
keywords = "Gluconeogenesis, Insulin, Phosphate, Urate",
author = "Christina Cicerchi and Nanxing Li and James Kratzer and Gabriela Garcia and Roncal-Jimenez, {Carlos A.} and Katsuyuki Tanabe and Brandi Hunter and Rivard, {Christopher J.} and Sautin, {Yuri Y.} and Gaucher, {Eric A.} and Johnson, {Richard J.} and Lanaspa, {Miguel A.}",
year = "2014",
doi = "10.1096/fj.13-243634",
language = "English",
volume = "28",
pages = "3339--3350",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "8",

}

TY - JOUR

T1 - Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation

T2 - Evolutionary implications of the uricase loss in hominids

AU - Cicerchi, Christina

AU - Li, Nanxing

AU - Kratzer, James

AU - Garcia, Gabriela

AU - Roncal-Jimenez, Carlos A.

AU - Tanabe, Katsuyuki

AU - Hunter, Brandi

AU - Rivard, Christopher J.

AU - Sautin, Yuri Y.

AU - Gaucher, Eric A.

AU - Johnson, Richard J.

AU - Lanaspa, Miguel A.

PY - 2014

Y1 - 2014

N2 - Reduced AMP kinase (AMPK) activity has been shown to play a key deleterious role in increased hepatic gluconeogenesis in diabetes, but the mechanism whereby this occurs remains unclear. In this article, we document that another AMP-dependent enzyme, AMP deaminase (AMPD) is activated in the liver of diabetic mice, which parallels with a significant reduction in AMPK activity and a significant increase in intracellular glucose accumulation in human HepG2 cells. AMPD activation is induced by a reduction in intracellular phosphate levels, which is characteristic of insulin resistance and diabetic states. Increased gluconeogenesis is mediated by reduced TORC2 phosphorylation at Ser171 by AMPK in these cells, as well as by the up-regulation of the rate-limiting enzymes PEPCK and G6Pc. The mechanism whereby AMPD controls AMPK activation depends on the production of a specific AMP downstream metabolite through AMPD, uric acid. In this regard, humans have higher uric acid levels than most mammals due to a mutation in uricase, the enzyme involved in uric acid degradation in most mammals, that developed during a period of famine in Europe 1.5 × 10 7 yr ago. Here, working with resurrected ancestral uricases obtained from early hominids, we show that their expression on HepG2 cells is enough to blunt gluconeogenesis in parallel with an up-regulation of AMPK activity. These studies identify a key role AMPD and uric acid in mediating hepatic gluconeogenesis in the diabetic state, via a mechanism involving AMPK down-regulation and overexpression of PEPCK and G6Pc. The uricase mutation in the Miocene likely provided a survival advantage to help maintain glucose levels under conditions of near starvation, but today likely has a role in the pathogenesis of diabetes.

AB - Reduced AMP kinase (AMPK) activity has been shown to play a key deleterious role in increased hepatic gluconeogenesis in diabetes, but the mechanism whereby this occurs remains unclear. In this article, we document that another AMP-dependent enzyme, AMP deaminase (AMPD) is activated in the liver of diabetic mice, which parallels with a significant reduction in AMPK activity and a significant increase in intracellular glucose accumulation in human HepG2 cells. AMPD activation is induced by a reduction in intracellular phosphate levels, which is characteristic of insulin resistance and diabetic states. Increased gluconeogenesis is mediated by reduced TORC2 phosphorylation at Ser171 by AMPK in these cells, as well as by the up-regulation of the rate-limiting enzymes PEPCK and G6Pc. The mechanism whereby AMPD controls AMPK activation depends on the production of a specific AMP downstream metabolite through AMPD, uric acid. In this regard, humans have higher uric acid levels than most mammals due to a mutation in uricase, the enzyme involved in uric acid degradation in most mammals, that developed during a period of famine in Europe 1.5 × 10 7 yr ago. Here, working with resurrected ancestral uricases obtained from early hominids, we show that their expression on HepG2 cells is enough to blunt gluconeogenesis in parallel with an up-regulation of AMPK activity. These studies identify a key role AMPD and uric acid in mediating hepatic gluconeogenesis in the diabetic state, via a mechanism involving AMPK down-regulation and overexpression of PEPCK and G6Pc. The uricase mutation in the Miocene likely provided a survival advantage to help maintain glucose levels under conditions of near starvation, but today likely has a role in the pathogenesis of diabetes.

KW - Gluconeogenesis

KW - Insulin

KW - Phosphate

KW - Urate

UR - http://www.scopus.com/inward/record.url?scp=84905233774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905233774&partnerID=8YFLogxK

U2 - 10.1096/fj.13-243634

DO - 10.1096/fj.13-243634

M3 - Article

VL - 28

SP - 3339

EP - 3350

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 8

ER -